Animalcare Group Plc (ANCR) - Cash Flow Conversion Efficiency

Latest as of December 2025: 0.053x

Based on the latest financial reports, Animalcare Group Plc (ANCR) has a cash flow conversion efficiency ratio of 0.053x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (GBX6.12 Million ≈ $744.51 USD) by net assets (GBX114.54 Million ≈ $13.94K USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see ANCR company net worth for the company's overall valuation and market capitalisation.

Animalcare Group Plc - Cash Flow Conversion Efficiency Trend (2005–2025)

This chart illustrates how Animalcare Group Plc's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Animalcare Group Plc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Animalcare Group Plc ranked by their cash flow conversion efficiency. Explore Animalcare Group Plc cash earnings quality to measure how well operating cash flow supports reported net income.

Company Cash Flow Conversion Efficiency
P/F Atlantic Petroleum
CO:ATLA-DKK
0.006x
B P Marsh and Partners PLC
LSE:BPM
-0.015x
AH-Vest Limited
JSE:AHL
-0.211x
Falcon Gold Corp
V:FG
-0.004x
ICZOOM Group Inc. Class A Ordinary Shares
NASDAQ:IZM
0.083x
Baillie Gifford UK Growth Fund PLC
LSE:BGUK
0.007x
Genprex Inc
NASDAQ:GNPX
-0.347x
Goenka Diamond and Jewels Limited
NSE:GOENKA
0.000x

Annual Cash Flow Conversion Efficiency for Animalcare Group Plc (2005–2025)

The table below shows the annual cash flow conversion efficiency of Animalcare Group Plc from 2005 to 2025. View Animalcare Group Plc (ANCR) share price today for real-time trading data and today's change.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 GBX114.54 Million
≈ $13.94K
GBX10.92 Million
≈ $1.33K
0.095x -9.50%
2024-12-31 GBX113.31 Million
≈ $13.79K
GBX11.93 Million
≈ $1.45K
0.105x -20.21%
2023-12-31 GBX77.89 Million
≈ $9.48K
GBX10.28 Million
≈ $1.25K
0.132x +10.56%
2022-12-31 GBX78.99 Million
≈ $9.61K
GBX9.43 Million
≈ $1.15K
0.119x -32.92%
2021-12-31 GBX78.80 Million
≈ $9.59K
GBX14.02 Million
≈ $1.71K
0.178x +30.61%
2020-12-31 GBX81.59 Million
≈ $9.93K
GBX11.12 Million
≈ $1.35K
0.136x -14.87%
2019-12-31 GBX81.89 Million
≈ $9.96K
GBX13.11 Million
≈ $1.59K
0.160x +86.52%
2018-12-31 GBX86.59 Million
≈ $10.54K
GBX7.43 Million
≈ $904.02
0.086x +305.48%
2017-12-31 GBX89.64 Million
≈ $10.91K
GBX1.90 Million
≈ $230.81
0.021x -79.16%
2017-06-30 GBX23.84 Million
≈ $2.90K
GBX2.42 Million
≈ $294.57
0.102x -44.73%
2016-06-30 GBX22.52 Million
≈ $2.74K
GBX4.14 Million
≈ $503.23
0.184x -0.92%
2015-06-30 GBX20.99 Million
≈ $2.55K
GBX3.89 Million
≈ $473.54
0.185x +238.04%
2014-06-30 GBX19.45 Million
≈ $2.37K
GBX1.07 Million
≈ $129.82
0.055x -65.20%
2013-06-30 GBX17.96 Million
≈ $2.19K
GBX2.83 Million
≈ $344.45
0.158x +25.00%
2012-06-30 GBX16.84 Million
≈ $2.05K
GBX2.12 Million
≈ $258.31
0.126x -7.19%
2011-06-30 GBX15.79 Million
≈ $1.92K
GBX2.15 Million
≈ $260.98
0.136x -1.19%
2010-06-30 GBX14.08 Million
≈ $1.71K
GBX1.94 Million
≈ $235.56
0.137x -13.08%
2009-06-30 GBX15.38 Million
≈ $1.87K
GBX2.43 Million
≈ $296.03
0.158x +61.42%
2008-06-30 GBX14.64 Million
≈ $1.78K
GBX1.44 Million
≈ $174.60
0.098x -38.89%
2007-06-30 GBX6.14 Million
≈ $746.70
GBX984.00K
≈ $119.72
0.160x +44.40%
2006-06-30 GBX5.82 Million
≈ $707.88
GBX646.00K
≈ $78.60
0.111x +215.62%
2005-06-30 GBX5.68 Million
≈ $691.70
GBX200.00K
≈ $24.33
0.035x --

About Animalcare Group Plc

LSE:ANCR UK Drug Manufacturers - Specialty & Generic
Market Cap
$2.81 Million
GBX23.13 Billion GBX
Market Cap Rank
#29673 Global
#612 in UK
Share Price
GBX335.00
Change (1 day)
+0.00%
52-Week Range
GBX216.00 - GBX335.00
All Time High
GBX392.52
About

Animalcare Group plc develops, sells, and distributes licensed veterinary pharmaceuticals for the companion animal, production animal, and equine veterinary markets in Europe, the Asia-Pacific, and internationally. It operates through Animalcare Europe and Randlab segments. The company offers Orozyme, an enzymatic toothpaste for dental care in cats and dogs; Danilon, an oral treatment for pain in… Read more